Products for Research Use Only
RegisterLogin

Tafasitamab

CAT: 0804-HY-P9981-01Size: 1 mgDry Ice: YesHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-P9981-01Size:1 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Tafasitamab (XmAb5574) is an Fc-modified, humanized monoclonal antibody that binds to the human B-cell surface antigenCD19[1][2].
CAS Number
1422527-84-1
Product Name Alternative
XmAb5574; MOR00208; Tafasitamab-cxix; MOR-208
UNSPSC
12352203
Target
Apoptosis
Type
Inhibitory Antibodies
Related Pathways
Apoptosis
Applications
COVID-19-immunoregulation
Field of Research
Cancer; Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/tafasitamab.html
Purity
99.71
Solubility
H2O
Smiles
[Tafasitamab]
Molecular Weight
(147.42 kDa)
References & Citations
[1]Jung Hyun Her, et al. Tafasitamab mediates killing of B-cell non-Hodgkin's lymphoma in combination with γδ T cell or allogeneic NK cell therapy. Cancer Immunol Immunother. 2022 Mar 29.|[2]Holly M Horton, et al. Potent in vitro and in vivo activity of an Fc-engineered anti-CD19 monoclonal antibody against lymphoma and leukemia. Cancer Res
Shipping Conditions
Dry Ice
Storage Conditions
Store at -80°C for 2 years
Scientific Category
Inhibitory Antibodies
Clinical Information
Launched

Alternative Products

CatalogName
MBS5819056Tafasitamab
592225Tafasitamab (CD19)
CBA1075-01Tafasitamab Biosimilar
GTR18337625-01Tafasitamab Antibody
047738CD19 (tafasitamab) discontinued
MBS1563540-01Research Grade Tafasitamab
A2563-01Tafasitamab (Anti-CD19)
AB996018Tafasitamab ELISA Kit
E55B0751Tafasitamab (Reference antibody)
ABS-216-100ugTafasitamab Biosimilar, Research Grade

Popular Products